ADEPT: Adaptive Trial for Treatment of Depressive Symptoms Associated With Concussion Using Repetitive Transcranial Magnetic Stimulation Protocols
Depressive Symptoms · Mild Traumatic Brain Injury · Concussion
Enrolment: 198 · Results not recorded
Device · Physical/gene-therapy combination; no ChEMBL entity. The rTMS component is extensively trialled in humans (1257 ClinicalTrials.gov records for the keyword; 9 relevance-filtered here, prioritising trauma, brain injury and neurological indications). The AAV2-delivered electromagnetic-perceptive gene (EPG) component has no human trial and remains preclinical.
2 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Depressive Symptoms · Mild Traumatic Brain Injury · Concussion
Enrolment: 198 · Results not recorded
Neuropathic Pain · Spinal Cord Injury
Enrolment: 26 · Results not recorded
Major Depressive Disorder
Enrolment: 20 · Results not recorded
Aphasia · Stroke
Enrolment: 25 · Results not recorded
Parkinson Disease
Enrolment: 64 · Results not recorded
Parkinson Disease
Enrolment: 40 · Results not recorded
Major Depressive Disorder
Enrolment: 50 · Results not recorded
Treatment Resistant Depression
Enrolment: 30 · Results not recorded
Tinnitus
Enrolment: 80 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Right forepaw denervation with radial, median and ulnar nerves cut and a 5 mm gap made in each
Both acute and delayed rTMS and EPG magnetic neuromodulation improved motor and exploratory behaviour and increased S1 fMRI activation and CaMKII expression, with only marginal effects on self-grooming.
Extraction: extract · Supplied extraction confidence: 0.88. Machine-extracted fields require source verification.